Minerva Neurosciences, Inc. (NERV) Free cash flow 2018–2023
Minerva Neurosciences, Inc. (NERV) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$14.8MFY2023 · since FY2018: -$42.0M → -$14.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$14.8M | — |
| FY2018 | -$42.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice